{"id":970469,"date":"2026-06-04T07:03:19","date_gmt":"2026-06-04T11:03:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/"},"modified":"2026-06-04T07:03:19","modified_gmt":"2026-06-04T11:03:19","slug":"insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/","title":{"rendered":"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod<sup>\u00ae<\/sup> Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b><i>Presentations will feature next generation Omnipod innovations designed to reduce user effort, new algorithm data, and clinical evidence demonstrating improved time in range<\/i><\/b><\/li>\n<li><b><i>Insulet-led sessions will highlight how patient-centered design and strong clinical performance is helping redefine Automated Insulin Delivery (AID) across type 1 and type 2 diabetes<\/i><\/b><\/li>\n<\/ul>\n<p>ACTON, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nInsulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.omnipod.com%2F&amp;esheet=54547060&amp;newsitemid=20260604228498&amp;lan=en-US&amp;anchor=tubeless+insulin+pump+technology&amp;index=1&amp;md5=b3294d0176ecfd56eb4ea1e393aa4d19\">tubeless insulin pump technology<\/a> with its Omnipod<sup>\u00ae<\/sup> brand of products, today announced its planned activities during the American Diabetes Association (ADA) 86th Scientific Sessions, taking place June 5 \u2013 8, 2026 in New Orleans.<\/p>\n<p>\n\u201cAt Insulet, we believe diabetes technology should do more and demand less from the people who rely on it every day,\u201d said Ashley McEvoy, President and CEO of Insulet. \u201cThe data and innovations we\u2019re sharing at ADA reflect this commitment, showing how Omnipod is advancing AID by improving outcomes, reducing disease burden, and unlocking barriers to AID adoption.\u201d<\/p>\n<p>\nInsulet\u2019s presence at ADA highlights Omnipod\u2019s latest planned innovations, supported by clinical data demonstrating the performance of its next-generation products. This follows the most significant <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.insulet.com%2Fnews%2Fnews-details%2F2026%2FInsulet-Announces-U-S--Rollout-of-Enhanced-Omnipod-5-Algorithm-and-Expands-Compatibility-with-Abbotts-FreeStyle-Libre-3-Plus-Sensor%2Fdefault.aspx&amp;esheet=54547060&amp;newsitemid=20260604228498&amp;lan=en-US&amp;anchor=algorithm+update&amp;index=2&amp;md5=3fa532b1f67b5eff6379b5c0041537c5\">algorithm update <\/a>in the U.S. since Omnipod 5 launched in 2022. The enhanced Omnipod 5 algorithm features a lower Target Glucose setting for more time in range, updated alarm handling designed for fewer interruptions and increased time in Automated Mode, and integration with Abbott\u2019s FreeStyle Libre 3 Plus sensor.<\/p>\n<p>\nThe Company will also share detailed information about STRIVE, EVOLUTION 3, and other milestone studies throughout ADA. STRIVE is the pivotal trial supporting the regulatory submission of the next generation Omnipod 6 Automated Insulin Delivery System. EVOLUTION 3 is the pre-pivotal study evaluating the safety and effectiveness of Insulet\u2019s fully closed-loop system for adults with type 2 diabetes.*<\/p>\n<p>\nInsulet is sponsoring a product theater presentation, <i>The Omnipod Difference: Patient-Centered Simplicity and Breakthrough Algorithm Performance<\/i>, on Sunday, June 7 from 10:15 \u2013 11:00 AM CT. Speakers will include:<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Dr. Sufyan Hussain<\/b>, MA, MB BChir, MRCP, PhD, Diabetes and Endocrine Physician, Guy\u2019s and St Thomas\u2019 Hospital, Adjunct Reader in Diabetes, King\u2019s College London\n<\/li>\n<li><b>Dr. Gregory Forlenza<\/b>, MD, MS, Associate Professor of Pediatrics &amp; Director of Pediatric Diabetes Technology Research H. Peter Chase, MD Endowed Chair, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus.\n<\/li>\n<li><b>Dr. Trang Ly<\/b>, MBBS, FRACP, PhD, Senior Vice President and Chief Medical Officer at Insulet\n<\/li>\n<\/ul>\n<p>\nInsulet will also host two Diabetes Learning Byte sessions at booth 1108 on Saturday, June 6.<\/p>\n<ul class=\"bwlistdisc\">\n<li><i>Advancing Type 2 Diabetes Care: A Simpler Path to AID, <\/i>from<i \/>11:00 \u2013 11:20 AM CT with Insulet\u2019s Dr. Jessica Lilley, MD, Senior Manager, Field Medical Affairs Team; and Dr. Anders Carlson, MD, Executive Director, International Diabetes Center, Associate Professor, University of Minnesota.\n<\/li>\n<li><i>Inside the Omnipod Algorithm: How Continuous Innovation Strengthens Automation and Outcomes, <\/i>from 2:20 \u2013 2:40 PM CT with Insulet\u2019s Joon Bok Lee, PhD, MBA, Senior Director, Advanced Algorithms; and Cari Berget, MPH, RN, CDCES, Senior Research Scientist, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus.\n<\/li>\n<\/ul>\n<p><b>Scientific Presentations<\/b><\/p>\n<p>\nInsulet researchers and collaborators will present additional clinical evidence and real-world outcome data as part of the program\u2019s oral and poster presentations:<\/p>\n<p><b>Oral Presentations<\/b><\/p>\n<p><i>Friday, June 5:<b \/>3:15 \u2013 3:30 PM CT<\/i><\/p>\n<p>\n1068-OR <b>Multicenter, Randomized Trial of a Next-Generation Algorithm for Omnipod in Individuals with Type 1 or Type 2 Diabetes: The STRIVE Trial <\/b>with Lori Laffel, MD<\/p>\n<p><i>Friday, June 5: 6:00 \u2013 6:15 PM CT<\/i><\/p>\n<p>\n1147-OR <b>Performance of a Next-Generation Algorithm for Omnipod in Adolescents and Adults with Type 1 Diabetes: Findings from the STRIVE Randomized Trial<\/b> with Davida Kruger, NP<\/p>\n<p><i>Sunday, June 7:<b \/>3:30 \u2013 3:45 PM CT<\/i><\/p>\n<p>\n1258-OR <b>Performance of a Next-Generation Algorithm for Omnipod in Adults with Type 2 Diabetes: Findings from the STRIVE Randomized Trial<\/b> with Anders Carlson, MD<\/p>\n<p><b>Poster Presentations<\/b><\/p>\n<p>\nPoster presentations will be held from 12:30 \u2013 1:30 PM CT in the Poster Hall during the weekend.<\/p>\n<p><i>Saturday, June 6<\/i><\/p>\n<p>\n1898-P\u2013 <b>Real-World Glycemic Outcomes in Early-Onset Type 2 Diabetes (T2D) With the Omnipod<sup>\u00ae<\/sup> 5 Automated Insulin Delivery (AID) System <\/b>with Michelle Van Name, MD<\/p>\n<p>\n1872-P\u2013 <b>Initiation of Omnipod<sup>\u00ae<\/sup> 5 Automated Insulin Delivery System Among Individuals with Type 2 Diabetes and Acute Glycemic Events Requiring Emergency Department and Inpatient Hospital Care <\/b>with Joshua Weinstein, PhD<\/p>\n<p>\n1880-P\u2013 <b>Performance of a Next-Generation Algorithm for Omnipod in Children with Type 1 Diabetes: Findings from the STRIVE Randomized Trial<\/b> with Daniel DeSalvo, MD<\/p>\n<p><i>Sunday, June 7<\/i><\/p>\n<p>\n2887-LB\u2013 <b>Real-World Glycemic Outcomes Using the Omnipod Discover Data Management System <\/b>with Pablo Mora, MD<\/p>\n<p>\n2881-LB\u2013 <b>Safety and Performance of a Fully Closed-Loop (FCL) Algorithm for Omnipod in Type 2 Diabetes: The EVOLUTION 3<\/b> Study with Lori Laffel, MD<\/p>\n<p><b><i>Booth Activities\/Investor Webcast<\/i><\/b><\/p>\n<p>\nInsulet will showcase its latest innovations, strong clinical outcomes, and new partnerships at the Omnipod Booth (booth #1918). Attendees can listen to live podcast recordings of <i>Beyond the Bolus<\/i> and <i>Within Range,<\/i> experience an interactive algorithm simulator, and get a hands-on demonstration of about Omnipod Discover<b>\u2122<\/b>, Insulet\u2019s retrospective data insights and reporting platform.<\/p>\n<p>\nIn addition, a Baird\u2011hosted webcast, \u201cADA Recap Interview with Dr. Trang Ly,\u201d will be facilitated by Jeff Johnson, Senior Research Analyst, on Monday, June 8, 2026, at 10:00 a.m. CT. The interview will recap conference highlights, new clinical data, and updates from ADA. A link to the webcast will be available on the Investor Relations section of the Company\u2019s website under Events and Presentations and will be archived for future replay.<\/p>\n<p>\n*Insulet\u2019s Omnipod 6 and FCL AID System are investigational devices. Limited by federal (or United States) law to investigational use. These products have not been reviewed by the FDA or any other regulatory agency.<\/p>\n<p><b><i>About Insulet Corporation:<\/i><\/b><\/p>\n<p>\nInsulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet\u2019s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Finsulet.com%2F&amp;esheet=54547060&amp;newsitemid=20260604228498&amp;lan=en-US&amp;anchor=Insulet.com&amp;index=3&amp;md5=90a47475c4061b84e3e9b3e68993fa41\">Insulet.com<\/a> or <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fomnipod.com&amp;esheet=54547060&amp;newsitemid=20260604228498&amp;lan=en-US&amp;anchor=omnipod.com&amp;index=4&amp;md5=6d86f7db7dea0e6020be59c88200e04c\">omnipod.com<\/a>.<\/p>\n<p>\n\u00a92026 Insulet Corporation. Omnipod is a registered trademark of Insulet Corporation. All rights reserved.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260604228498\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260604228498\/en\/<\/a><\/span><\/p>\n<p><b><i>Media:<br \/>\n<\/i><\/b><br \/>Cristal Downing<br \/>\n<br \/>Chief Corporate Affairs Officer<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:pr@insulet.com\">pr@insulet.com<\/a><\/p>\n<p><b><i>Investor Relations:<br \/>\n<\/i><\/b><br \/>Clare Trachtman<br \/>\n<br \/>Vice President, Investor Relations<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@insulet.com\">ir@insulet.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Massachusetts<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Technology Men Diabetes Health Consumer Other Technology Research Medical Devices Other Consumer Health Technology Science Women Seniors Clinical Trials<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260604228498\/en\/1711909\/3\/INSULET_Logo_RGB_No_tag.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions Presentations will feature next generation Omnipod innovations designed to reduce user effort, new algorithm data, and clinical evidence demonstrating improved time in range Insulet-led sessions will highlight how patient-centered design and strong clinical performance is helping redefine Automated Insulin Delivery (AID) across type 1 and type 2 diabetes ACTON, Mass.&#8211;(BUSINESS WIRE)&#8211; Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, today announced its planned activities during the American Diabetes Association (ADA) 86th Scientific Sessions, taking place June 5 \u2013 8, 2026 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-970469","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions Presentations will feature next generation Omnipod innovations designed to reduce user effort, new algorithm data, and clinical evidence demonstrating improved time in range Insulet-led sessions will highlight how patient-centered design and strong clinical performance is helping redefine Automated Insulin Delivery (AID) across type 1 and type 2 diabetes ACTON, Mass.&#8211;(BUSINESS WIRE)&#8211; Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, today announced its planned activities during the American Diabetes Association (ADA) 86th Scientific Sessions, taking place June 5 \u2013 8, 2026 &hellip; Continue reading &quot;Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-04T11:03:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions\",\"datePublished\":\"2026-06-04T11:03:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/\"},\"wordCount\":1167,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/\",\"name\":\"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-06-04T11:03:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/","og_locale":"en_US","og_type":"article","og_title":"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions - Market Newsdesk","og_description":"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions Presentations will feature next generation Omnipod innovations designed to reduce user effort, new algorithm data, and clinical evidence demonstrating improved time in range Insulet-led sessions will highlight how patient-centered design and strong clinical performance is helping redefine Automated Insulin Delivery (AID) across type 1 and type 2 diabetes ACTON, Mass.&#8211;(BUSINESS WIRE)&#8211; Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, today announced its planned activities during the American Diabetes Association (ADA) 86th Scientific Sessions, taking place June 5 \u2013 8, 2026 &hellip; Continue reading \"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-04T11:03:19+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions","datePublished":"2026-06-04T11:03:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/"},"wordCount":1167,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/","name":"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-06-04T11:03:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260604228498r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod\u00ae Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/970469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=970469"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/970469\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=970469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=970469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=970469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}